The following excerpt is from a recent review of the book Frontiers in Dengue Virus Research.

"an up-to-date and cutting-edge anthology from the leading experts in the dengue field. The chapters are balanced by contributions from established investigators who have dedicated their careers to DENV research with those from newcomers who have recently made significant contributions the study of DENV. ... the book addresses a range of important topics in DENV research. The authors identify many important questions that remain to be answered. The book will be considered as an important reference to DENV and other flavivirus researchers at the graduate level and beyond."

from Mark Schreiber et al (Novartis Institute for Tropical Diseases, Singapore) writing in the February 2010 issue of Expert Review of Vaccines read more ...

Frontiers in Dengue Virus Research

Labels: dengue, dengue virus, DENV

Dengue virus (DENV), a mosquito-borne flavivirus, is the causative agent of dengue fever, currently one of the most significant emerging disease challenges to global public health. Although dengue is an old disease, recent decades have seen an unprecedented increase in the geographic range, incidence, and severity of infection. The virus infects 100 million people annually and is endemic in many tropical and sub-tropical regions in the world.

At present, neither a licensed vaccine nor anti-viral drugs are available to control dengue disease, prompting a plethora of research initiatives aimed at understanding the molecular and cellular virology, genomics, and evolution of this important virus.

Further reading: Frontiers in Dengue Virus Research

Labels: dengue, dengue disease, dengue fever, dengue virus, DENV, flavivirus